Profile for BioXcel Therapeutics Inc. (BTAI)

$ 46.52   0.87 (+1.91%) Volume: 308.03k 4:00 PM EDT Oct 23, 2020
After Hours:  $ 45.25   -1.27 (-2.73%) Volume: 12.02k 6:18 PM EDT Oct 23, 2020
Business Description:
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company which is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology.
Address: 555 Long Wharf Drive, 12th Floor, New Haven, CT, US, 06511
Telephone: +1 475 238-6837 Website: https://www.bioxceltherapeutics.com
Facsimile: +1 475 238-6837 Email: [email protected]
Details
CEO: Vimal Mehta
Employees: 36 Market Cap: 1.04b
Issue Type: CS
Auditor: BDO USA, LLP
Last Audit: Unqualified Opinion
Indices: N/A
Industry Classifications
Sector: Healthcare CIK: 1720893
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Pharmaceutical Preparation Manufacturing (325412)
SIC: Pharmaceutical Preparations (2834)